Inogen, Inc. (NASDAQ:INGN) Short Interest Update

Inogen, Inc. (NASDAQ:INGN) saw a large increase in short interest in January. As of January 31st, there was short interest totalling 798,600 shares, an increase of 8.8% from the January 15th total of 734,000 shares. Based on an average daily volume of 224,800 shares, the days-to-cover ratio is currently 3.6 days.

Institutional Investors Weigh In On Inogen

A number of hedge funds have recently added to or reduced their stakes in the business. Northern Trust Corp increased its holdings in Inogen by 3.5% in the fourth quarter. Northern Trust Corp now owns 198,298 shares of the medical technology company’s stock worth $1,818,000 after purchasing an additional 6,690 shares in the last quarter. Tudor Investment Corp ET AL increased its holdings in Inogen by 44.9% in the fourth quarter. Tudor Investment Corp ET AL now owns 82,852 shares of the medical technology company’s stock worth $760,000 after purchasing an additional 25,681 shares in the last quarter. Boothbay Fund Management LLC increased its holdings in Inogen by 48.5% in the fourth quarter. Boothbay Fund Management LLC now owns 17,721 shares of the medical technology company’s stock worth $163,000 after purchasing an additional 5,785 shares in the last quarter. Susquehanna Fundamental Investments LLC bought a new stake in Inogen in the fourth quarter worth approximately $233,000. Finally, Price T Rowe Associates Inc. MD increased its holdings in shares of Inogen by 5.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 26,710 shares of the medical technology company’s stock valued at $245,000 after acquiring an additional 1,318 shares in the last quarter. 89.94% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently commented on INGN. StockNews.com upgraded Inogen from a “hold” rating to a “buy” rating in a research report on Monday, February 10th. Needham & Company LLC reaffirmed a “hold” rating on shares of Inogen in a research note on Thursday, January 30th.

Inogen Price Performance

Shares of Inogen stock traded down $0.02 during midday trading on Friday, reaching $10.64. The company had a trading volume of 340,965 shares, compared to its average volume of 262,340. The stock has a fifty day moving average price of $10.07 and a 200 day moving average price of $10.24. The firm has a market cap of $253.44 million, a PE ratio of -4.73 and a beta of 1.02. Inogen has a fifty-two week low of $5.82 and a fifty-two week high of $13.33.

About Inogen

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.